QUETIAPIN RATIOPHARM 200 mg tabletti, kalvopäällysteinen Suomi - suomi - Fimea (Suomen lääkevirasto)

quetiapin ratiopharm 200 mg tabletti, kalvopäällysteinen

ratiopharm gmbh - quetiapini fumaras - tabletti, kalvopäällysteinen - 200 mg - ketiapiini

QUETIAPIN RATIOPHARM 300 mg tabletti, kalvopäällysteinen Suomi - suomi - Fimea (Suomen lääkevirasto)

quetiapin ratiopharm 300 mg tabletti, kalvopäällysteinen

ratiopharm gmbh - quetiapini fumaras - tabletti, kalvopäällysteinen - 300 mg - ketiapiini

LISVY 60 / 13 mikrog / 24 tuntia depotlaastari Suomi - suomi - Fimea (Suomen lääkevirasto)

lisvy 60 / 13 mikrog / 24 tuntia depotlaastari

gedeon richter plc - ethinylestradiolum,gestodenum - depotlaastari - 60 / 13 mikrog / 24 tuntia - gestodeeni ja etinyyliestradioli

Tremfya Euroopan unioni - suomi - EMA (European Medicines Agency)

tremfya

janssen-cilag international nv - guselkumab - psoriasis - immunosuppressantit - plaque psoriasis tremfya is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy. psoriatic arthritis tremfya, alone or in combination with methotrexate (mtx), is indicated for the treatment of active psoriatic arthritis in adult patients who have had an inadequate response or who have been intolerant to a prior disease-modifying antirheumatic drug (dmard) therapy (see section 5.

Dovprela (previously Pretomanid FGK) Euroopan unioni - suomi - EMA (European Medicines Agency)

dovprela (previously pretomanid fgk)

mylan ire healthcare limited - pretomanid - tuberkuloosi, monilääkeresistenssi - mykobakteerilÄÄkkeet - dovprela is indicated in combination with bedaquiline and linezolid, in adults, for the treatment of pulmonary extensively drug resistant (xdr), or treatment-intolerant or nonresponsive multidrug-resistant (mdr) tuberculosis (tb). on otettava huomioon viralliset ohjeet antibioottien tarkoituksenmukaisesta käytöstä.

Imcivree Euroopan unioni - suomi - EMA (European Medicines Agency)

imcivree

rhythm pharmaceuticals netherlands b.v. - setmelanotide - liikalihavuus - antiobesity preparations, excl. ruokavalion tuotteita - imcivree is indicated for the treatment of obesity and the control of hunger associated with genetically confirmed bardet biedl syndrome (bbs), loss-of-function biallelic pro-opiomelanocortin (pomc), including pcsk1, deficiency or biallelic leptin receptor (lepr) deficiency in adults and children 6 years of age and above.

Carvykti Euroopan unioni - suomi - EMA (European Medicines Agency)

carvykti

janssen-cilag international nv - ciltacabtagene autoleucel - multiple myeloma - carvykti is indicated for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor and an anti-cd38 antibody and have demonstrated disease progression on the last therapy.

Ibuprofen Zentiva 800 mg tabletti, kalvopäällysteinen Suomi - suomi - Fimea (Suomen lääkevirasto)

ibuprofen zentiva 800 mg tabletti, kalvopäällysteinen

zentiva, k.s. - ibuprofen - tabletti, kalvopäällysteinen - 800 mg - ibuprofeeni

Ibuprofen Zentiva 600 mg tabletti, kalvopäällysteinen Suomi - suomi - Fimea (Suomen lääkevirasto)

ibuprofen zentiva 600 mg tabletti, kalvopäällysteinen

zentiva, k.s. - ibuprofen - tabletti, kalvopäällysteinen - 600 mg - ibuprofeeni

Ibuprofen Zentiva 400 mg tabletti, kalvopäällysteinen Suomi - suomi - Fimea (Suomen lääkevirasto)

ibuprofen zentiva 400 mg tabletti, kalvopäällysteinen

zentiva, k.s. - ibuprofen - tabletti, kalvopäällysteinen - 400 mg - ibuprofeeni